A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019

S Jugl, A Okpeku, B Costales, EJ Morris… - Medical Cannabis and …, 2021 - karger.com
Abstract In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM)
report comprehensively evaluated the body of evidence regarding cannabis health effects …

Role of cannabis and its derivatives in gastrointestinal and hepatic disease

J Gotfried, T Naftali, R Schey - Gastroenterology, 2020 - Elsevier
Medical and recreational cannabis use has increased dramatically over the last decade,
resulting from mainstream cultural acceptance and legalization in several countries …

Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomised controlled trial

T Naftali, L Bar-Lev Schleider, S Almog… - Journal of Crohn's …, 2021 - academic.oup.com
Aims Despite reports that medical cannabis improves symptoms in Crohn's disease [CD],
controlled studies evaluating disease response are lacking. This study assessed the effect of …

The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study

D Glickman, S Dalessio… - Inflammatory bowel …, 2024 - academic.oup.com
Background Cannabis use is common in inflammatory bowel disease (IBD). Recent studies
demonstrated that use of cannabis may relieve symptoms; however, it is still unclear how …

[HTML][HTML] The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

V Rakotoarivelo, TZ Mayer, M Simard, N Flamand… - Molecules, 2024 - mdpi.com
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis
has been used for several millennia to treat inflammatory disorders such as rheumatism or …

Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress

V Cocetta, P Governa, V Borgonetti, M Tinazzi… - Frontiers in …, 2021 - frontiersin.org
The relevance and incidence of intestinal bowel diseases (IBD) have been increasing over
the last 50 years and the current therapies are characterized by severe side effects, making …

A systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and …

BH Doeve, MM Van De Meeberg… - Journal of Clinical …, 2021 - journals.lww.com
Results: The search identified 682 records of which 15 nonrandomized studies and 5
randomized controlled trials were eligible for inclusion. The meta-analysis of the primary …

An overview of cannabis based treatment in Crohn's disease

T Naftali - Expert Review of Gastroenterology & Hepatology, 2020 - Taylor & Francis
Introduction: Cannabis use among inflammatory bowel disease (IBD) patients is common.
There are many studies of various laboratory models demonstrating the anti–inflammatory …

Cannabinoid therapeutic effects in inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials

A Vinci, F Ingravalle, D Bardhi, N Cesaro, S Frassino… - Biomedicines, 2022 - mdpi.com
(1) Introduction: Inflammatory Bowel Disease (IBD) patients may benefit from cannabinoid
administration supplementary therapy; currently no consensus on its effect has been …

Cannabis in gastroenterology: watch your head! A review of use in inflammatory bowel disease, functional gut disorders, and gut-related adverse effects

Y Nasser, M Woo, CN Andrews - Current Treatment Options in …, 2020 - Springer
Purpose of review To review recent clinical evidence surrounding the use of cannabinoids
and cannabis in gastrointestinal diseases, particularly inflammatory bowel disease (IBD) …